Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients.
Charles T LeeEric J LehrerAbhishek AphaleMiriam LangoThomas J GallowayNicholas G ZaorskyPublished in: Cancer (2019)
For T1-T2N0 skin cancers, BT and MMS have improved cosmesis over EBRT and CE. It is unclear whether this is because of treatment superiority or selection and reporting bias. Local control is similar among all modalities at 1 year.
Keyphrases
- skin cancer
- end stage renal disease
- radiation therapy
- chronic kidney disease
- ejection fraction
- newly diagnosed
- high dose
- locally advanced
- early stage
- prognostic factors
- radiation induced
- squamous cell carcinoma
- coronary artery bypass
- low dose
- acute coronary syndrome
- combination therapy
- soft tissue
- adverse drug
- case control
- replacement therapy